Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 4
1984 6
1985 4
1986 1
1988 3
1992 2
1993 4
1994 3
1995 4
1996 3
1997 7
1998 5
1999 5
2000 5
2001 9
2002 6
2003 5
2004 6
2005 6
2006 2
2007 6
2008 5
2009 4
2010 6
2011 6
2012 2
2013 3
2014 5
2015 5
2016 7
2017 4
2018 2
2019 7
2020 5
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

151 results
Results by year
Filters applied: . Clear all
Page 1
Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma.
Armand P, Rodig S, Melnichenko V, Thieblemont C, Bouabdallah K, Tumyan G, Özcan M, Portino S, Fogliatto L, Caballero MD, Walewski J, Gulbas Z, Ribrag V, Christian B, Perini GF, Salles G, Svoboda J, Zain J, Patel S, Chen PH, Ligon AH, Ouyang J, Neuberg D, Redd R, Chatterjee A, Balakumaran A, Orlowski R, Shipp M, Zinzani PL. Armand P, et al. Among authors: caballero md. J Clin Oncol. 2019 Dec 1;37(34):3291-3299. doi: 10.1200/JCO.19.01389. Epub 2019 Oct 14. J Clin Oncol. 2019. PMID: 31609651 Free PMC article. Clinical Trial.
Plitidepsin: design, development, and potential place in therapy.
Alonso-Álvarez S, Pardal E, Sánchez-Nieto D, Navarro M, Caballero MD, Mateos MV, Martín A. Alonso-Álvarez S, et al. Among authors: caballero md. Drug Des Devel Ther. 2017 Jan 19;11:253-264. doi: 10.2147/DDDT.S94165. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 28176904 Free PMC article. Review.
Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group).
Garcia-Sanz R, Sureda A, de la Cruz F, Canales M, Gonzalez AP, Pinana JL, Rodriguez A, Gutierrez A, Domingo-Domenech E, Sanchez-Gonzalez B, Rodriguez G, Lopez J, Moreno M, Rodriguez-Salazar MJ, Jimenez-Cabrera S, Caballero MD, Martinez C. Garcia-Sanz R, et al. Among authors: caballero md. Ann Oncol. 2019 Apr 1;30(4):612-620. doi: 10.1093/annonc/mdz009. Ann Oncol. 2019. PMID: 30657848 Free article. Clinical Trial.
R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.
Martín A, Conde E, Arnan M, Canales MA, Deben G, Sancho JM, Andreu R, Salar A, García-Sanchez P, Vázquez L, Nistal S, Requena MJ, Donato EM, González JA, León A, Ruiz C, Grande C, González-Barca E, Caballero MD; Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea (GEL/TAMO Cooperative Group). Martín A, et al. Among authors: caballero md. Haematologica. 2008 Dec;93(12):1829-36. doi: 10.3324/haematol.13440. Epub 2008 Oct 22. Haematologica. 2008. PMID: 18945747 Free article.
Randomized Phase II Trial Comparing Obinutuzumab (GA101) With Rituximab in Patients With Relapsed CD20+ Indolent B-Cell Non-Hodgkin Lymphoma: Final Analysis of the GAUSS Study.
Sehn LH, Goy A, Offner FC, Martinelli G, Caballero MD, Gadeberg O, Baetz T, Zelenetz AD, Gaidano G, Fayad LE, Buckstein R, Friedberg JW, Crump M, Jaksic B, Zinzani PL, Padmanabhan Iyer S, Sahin D, Chai A, Fingerle-Rowson G, Press OW. Sehn LH, et al. Among authors: caballero md. J Clin Oncol. 2015 Oct 20;33(30):3467-74. doi: 10.1200/JCO.2014.59.2139. Epub 2015 Aug 17. J Clin Oncol. 2015. PMID: 26282650 Free PMC article. Clinical Trial.
Characterizing college science instruction: The Three-Dimensional Learning Observation Protocol.
Bain K, Bender L, Bergeron P, Caballero MD, Carmel JH, Duffy EM, Ebert-May D, Fata-Hartley CL, Herrington DG, Laverty JT, Matz RL, Nelson PC, Posey LA, Stoltzfus JR, Stowe RL, Sweeder RD, Tessmer SH, Underwood SM, Urban-Lurain M, Cooper MM. Bain K, et al. Among authors: caballero md. PLoS One. 2020 Jun 16;15(6):e0234640. doi: 10.1371/journal.pone.0234640. eCollection 2020. PLoS One. 2020. PMID: 32544166 Free PMC article.
Exportin-1 E571K mutation is a common finding in patients with classical Hodgkin lymphoma.
Navarro-Bailón A, Jiménez C, Alonso-Álvarez S, Alcoceba M, González-Calle V, Chillón MC, García-Álvarez M, Prieto I, Medina A, González M, Caballero MD, Blanco Ó, Díaz LG, García-Sanz R, Sarasquete ME. Navarro-Bailón A, et al. Among authors: caballero md. Hematol Oncol. 2019 Apr;37(2):215-218. doi: 10.1002/hon.2570. Epub 2019 Jan 8. Hematol Oncol. 2019. PMID: 30548996 No abstract available.
Is Good Clinical Practice Becoming Poor Clinical Care?
Le Gouill S, Dreyling M, Caballero MD, Andre M, Doorduijn J, Jurczak W, Jerkeman M, Ghia P, Zinzani PL, Da Silva MG, Dimopoulos M, Trneny M, Delarue R, Walewski J, Gisselbrecht C, López-Guillermo A, Rule S. Le Gouill S, et al. Among authors: caballero md. Hemasphere. 2017 Dec 20;1(1):e4. doi: 10.1097/HS9.0000000000000004. eCollection 2017 Dec. Hemasphere. 2017. PMID: 31723733 Free PMC article. No abstract available.
151 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page